Perspectives on Subcutaneous Infliximab for Rheumatic Diseases and Inflammatory Bowel Disease: Before, During, and After the Covid-19 Era

AuthID
 P-00V-XM6
13
Author(s)
Schreiber, S
·
Alten, R
·
Westhovens, R
·
Peyrin Biroulet, L
·
Danese, S
·
Takeuchi, K
·
Magro, F
·
An, Y
·
Kim, DH
·
Yoon, S
·
Document Type
Review
Year published
2022
Published
in ADVANCES IN THERAPY, ISSN: 0741-238X
Volume: 39, Issue: 6, Pages: 2342-2364 (23)
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 34988877
Scopus: 2-s2.0-85122363368
Wos: WOS:000739243600001
Source Identifiers
ISSN: 0741-238X
Export Publication Metadata
Marked List
 Add to Marked List
Citations
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Full Text
Full Text @ sfx.b-on.pt

footer slogan

Useful Links

Get Help

© 2026 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service